Loading data
TOVXNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 8.6 m USD | 12.03 m USD | 14.31 m USD | 11.72 m USD | 7.8 m USD |
| Operating profit | -24.05 m USD | -26.35 m USD | -21.43 m USD | -21.58 m USD | -14.27 m USD |
| Profit before tax | -23.74 m USD | -25.65 m USD | -19.99 m USD | -21.11 m USD | -14.27 m USD |
| Income tax expense | — | 0 USD | -1.64 m USD | -1.43 m USD | 0 USD |
| Net income (reported basis) | -23.74 m USD | -25.65 m USD | -18.35 m USD | -20.03 m USD | -14.27 m USD |
| Net income attributable to common shareholders | -25.25 m USD | -25.65 m USD | -18.35 m USD | -20.03 m USD | -23.19 m USD |
| Basic earnings per share | -2.08 USD/share | -19.03 USD/share | -28.48 USD/share | -1.31 USD/share | -1.9 USD/share |
| Diluted earnings per share | -2.08 USD/share | -19.03 USD/share | -28.48 USD/share | -1.31 USD/share | -1.9 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.